Characteristics and outcomes of patients with multiple myeloma aged 21-40 years versus 41-60 years: a multi-institutional case-control study

Author:

Jurczyszyn Artur1,Nahi Hareth2,Avivi Irit3,Gozzetti Alessandro4,Niesvizky Ruben5,Yadlapati Sujitha5,Jayabalan David S.5,Robak Paweł6,Pika Tomas7,Andersen Kristian T.8,Rasche Leo9,Mądry Krzysztof10,Woszczyk Dariusz11,Raźny Małgorzata12,Usnarska-Zubkiewicz Lidia13,Knopińska-Posłuszny Wanda14,Wojciechowska Małgorzata15,Guzicka-Kazimierczak Renata16,Joks Monika17,Grosicki Sebastian18,Ciepłuch Hanna19,Rymko Marcin20,Vesole David H.21,Castillo Jorge J.22

Affiliation:

1. Jagiellonian University Medical College Department of Haematology; Cracow Poland

2. Karolinska University Hospital; Stockholm Sweden

3. Tel Aviv Medical Centre; Tel Aviv Israel

4. Azienda Ospedaliera Universitaria Senese; Siena Italy

5. Weill Cornell Medical College; New York NY USA

6. Department of Haematology; Medical University of Lodz, Copernicus Memorial Hospital; Lodz Poland

7. University Hospital Olomouc; Olomouc Czech Republic

8. Department of Medicine; Vejle Hospital; Vejle Denmark

9. UAMS Myeloma Institute; Little Rock AR USA

10. Medical University; Warsaw Poland

11. Department of Haematology; State Hospital; Opole Poland

12. Department of Haematology; State Hospital; Kraków Poland

13. Wroclaw Medical University; Wroclaw Poland

14. Ministry of the Interior Hospital in Olsztyn with Warmia and Masuria Oncology Centre; Olsztyn Poland

15. Department of Haematology; State Hospital; Olsztyn Poland

16. Pomeranian Medical University; Szczecin Poland

17. Department of Haematology and Bone Marrow Transplantation; Poznan University of Medical Sciences; Poznan Poland

18. Department of Cancer Prevention; School of Public Health, Medical University of Silesia; Katowice Poland

19. Copernicus. Regional Oncology Centre; Gdańsk Poland

20. Department of Haematology; District Hospital in Torun; Toruń Poland

21. John Theurer Cancer Center, Hackensack University Medical Center; Hackensack NJ USA

22. Dana-Farber Cancer Institute, Harvard Medical School; Boston MA USA

Publisher

Wiley

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3